BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37715188)

  • 1. Axillary ultrasound for predicting response to neoadjuvant treatment in breast cancer patients-a single institution experience.
    Pislar N; Gasljevic G; Music MM; Borstnar S; Zgajnar J; Perhavec A
    World J Surg Oncol; 2023 Sep; 21(1):292. PubMed ID: 37715188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The validity and clinical utility of axillary ultrasonography-guided fine needle aspiration biopsy in detection of nodal metastasis in early-stage breast cancer patients: a retrospective single-center experience.
    Taşçı F; Metin Y; Metin NO; Kadıoğlu ME; Gözükara MG; Kul S
    Turk J Med Sci; 2022 Aug; 52(4):1160-1168. PubMed ID: 36326392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine Axillary Ultrasound for Patients with T1-T2 Breast Cancer Does Not Increase the Rate of Axillary Lymph Node Dissection Based on Predictive Modeling.
    Wellington J; Sanders T; Mylander C; Alden A; Harris C; Buras R; Tafra L; Liang W; Stelle L; Rosman M; Jackson RS
    Ann Surg Oncol; 2018 Aug; 25(8):2271-2278. PubMed ID: 29868976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Accuracy of Axillary Ultrasound for Prediction of Axillary Pathologic Response after Neoadjuvant Treatment in Breast Cancer.
    Tasdoven I; Erdemir RU; Cakmak GK
    Chirurgia (Bucur); 2021; 116(2 Suppl):45-58. PubMed ID: 33963694
    [No Abstract]   [Full Text] [Related]  

  • 5. Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer.
    Zetterlund L; Celebioglu F; Axelsson R; de Boniface J; Frisell J
    Breast Cancer Res Treat; 2017 May; 163(1):93-101. PubMed ID: 28213781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-operative axillary ultrasound with fine-needle aspiration cytology performance and predictive factors of false negatives in axillary lymph node involvement in early breast cancer.
    Hotton J; Salleron J; Henrot P; Buhler J; Leufflen L; Rauch P; Marchal F
    Breast Cancer Res Treat; 2020 Oct; 183(3):639-647. PubMed ID: 32737710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axillary ultrasound during neoadjuvant systemic therapy in triple-negative breast cancer patients.
    Candelaria RP; Adrada BE; Hess K; Santiago L; Lane DL; Thompson AM; Moulder SL; Huang ML; Arribas EM; Rauch GM; Leung JWT; Symmans WF; Valero V; Ravenberg EE; White JB; Yang WT
    Eur J Radiol; 2020 Sep; 130():109170. PubMed ID: 32777736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of breast cancer subtypes on axillary ultrasound accuracy: A retrospective single center analysis of 583 women.
    Helfgott R; Mittlböck M; Miesbauer M; Moinfar F; Haim S; Mascherbauer M; Schlagnitweit P; Heck D; Knauer M; Fitzal F
    Eur J Surg Oncol; 2019 Apr; 45(4):538-543. PubMed ID: 30366878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Axillary Lymph Node Marking with Magseed® before and after Neoadjuvant Systemic Therapy in Breast Cancer Patients: MAGNET Study.
    Martínez M; Jiménez S; Guzmán F; Fernández M; Arizaga E; Sanz C
    Breast J; 2022; 2022():6111907. PubMed ID: 35855102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of preoperative axillary ultrasonography in T1 breast tumours.
    del Riego J; Diaz-Ruiz MJ; Teixidó M; Ribé J; Vilagran M; Canales L; Sentís M;
    Eur Radiol; 2016 Apr; 26(4):1073-81. PubMed ID: 26162580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of pre-operative axillary ultrasound in assessment of axillary tumor burden in breast cancer patients: a systematic review and meta-analysis.
    Man V; Luk WP; Fung LH; Kwong A
    Breast Cancer Res Treat; 2022 Nov; 196(2):245-254. PubMed ID: 36138294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical utility of assessment of the axilla in women with suspicious screen detected breast lesions in the post Z0011 era.
    Farshid G; Kollias J; Grantley Gill P
    Breast Cancer Res Treat; 2015 Jun; 151(2):347-55. PubMed ID: 25904216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of axillary ultrasound (AUS) on axillary dissection in breast conserving surgery (BCS).
    Reyna C; Kiluk JV; Frelick A; Khakpour N; Laronga C; Lee MC
    J Surg Oncol; 2015 Jun; 111(7):813-8. PubMed ID: 25753101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal Axillary Ultrasound Excludes Heavy Nodal Disease Burden in Patients with Breast Cancer.
    Jackson RS; Mylander C; Rosman M; Andrade R; Sawyer K; Sanders T; Tafra L
    Ann Surg Oncol; 2015 Oct; 22(10):3289-95. PubMed ID: 26224404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer.
    Skarping I; Förnvik D; Zackrisson S; Borgquist S; Rydén L
    Breast Cancer Res Treat; 2021 Aug; 189(1):131-144. PubMed ID: 34120224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical utility of combining pre-operative axillary ultrasonography and fine needle aspiration cytology with radionuclide guided sentinel lymph node biopsy in breast cancer patients with palpable axillary lymph nodes.
    Usmani S; Ahmed N; Al Saleh N; abu Huda F; Amanguno HG; Amir T; al Kandari F
    Eur J Radiol; 2015 Dec; 84(12):2515-20. PubMed ID: 26474908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary ultrasound after neoadjuvant therapy reduces the false-negative rate of sentinel lymph node biopsy in patients with cytologically node-positive breast cancer.
    Liu Y; Wang Y; Feng S; Xu Z; Yao M; Huang X; Li P; Wu L; Liu C; Chen X; Liang C; Liu Z
    Breast Cancer Res Treat; 2023 Feb; 197(3):515-523. PubMed ID: 36513955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer.
    Zetterlund LH; Frisell J; Zouzos A; Axelsson R; Hatschek T; de Boniface J; Celebioglu F
    Breast Cancer Res Treat; 2017 May; 163(1):103-110. PubMed ID: 28224384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance).
    Boughey JC; Ballman KV; Hunt KK; McCall LM; Mittendorf EA; Ahrendt GM; Wilke LG; Le-Petross HT
    J Clin Oncol; 2015 Oct; 33(30):3386-93. PubMed ID: 25646192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does use of axillary ultrasound in clinically node-negative patients receiving neo-adjuvant systemic therapy for breast cancer lead to surgical overtreatment?
    Horwood C; Ma N; Hayek J; Terando AM; Agnese DM; Grignol V
    Breast J; 2020 Feb; 26(2):120-124. PubMed ID: 31435992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.